期刊文献+

琥珀酸美托洛尔缓释片治疗慢性充血性心功能不全的疗效观察 被引量:13

Observation of curative effect of metoprolol succinate sustdined-release table in the treatment of chronic congestive heart failure
下载PDF
导出
摘要 目的:观察琥珀酸美托洛尔缓释片治疗慢性充血性心力衰竭的疗效。方法:慢性充血性心力衰竭患者89例,随机分为对照组44例与治疗组45例。对照组给予常规抗心力衰竭治疗;治疗组在对照组治疗基础上加用琥珀酸美托洛尔缓释片47.5 mg,1次/d,逐渐增加至97 mg,1次/d。结果:治疗组临床症状改善总有效率为88.9%,明显高于对照组72.7%(P<0.05);两组治疗后心脏射血分数、B型钠尿肽较治疗前明显改善(P<0.01),且治疗组优于对照组(P<0.05);患者再发心力衰竭及心血管原因的死亡均减少。结论:琥珀酸美托洛尔缓释片在常规治疗心力衰竭基础上能显著改善患者临床症状及心功能,并有利于心力衰竭患者的二级预防。 Objective To investigate the curative effect of metoprolol succinate sustdined-release tablet in treating chronic congestive heart failure. Methods A total of 89 patients with chronic congestive heart failure were randomly divided into treatment group and control group. Control group was treated with conventional therapy for heart failure, while the treatment group was treated with metoprolol succinate sustdined-release tablet at an initial dose of 11.88 mg once a day but gradually increased to 97 mg once a day,in addition to the conventional therapy. Results The total responsive rate in the treatment group(88.9%) was significantly higher than in control group(72.3%) (P〈0.05). The ejection fraction in both groups had significant improvement as compared with before treatment(P 〈0.01), with the treatment group showing a better improvement than in control group(P〈0.05). Conclusion Administration of metoprolol succinate sustdined-release tablet plus the conventional therapy can significantly improve the clinical symptoms and cardiac function in patients with chronic congestive heart failure.
作者 刘敏
出处 《实用诊断与治疗杂志》 2008年第3期175-176,179,共3页 Journal of Practical Diagnosis and Therapy
关键词 慢性充血性心力衰竭 琥珀酸美托洛尔缓释片 心功能 Chronic congestive heart failure metoprolol succinate sustained-release tablet cardiac function
  • 相关文献

参考文献8

二级参考文献12

  • 1MERIT-HF Study Group. Effect of metoprolol CR/XL in chronic heart failure; Metoprolo CR/XL randomized intervention trial in congestive heart failure(MERIT-HF) [J].Lancet, 1999,353 (9169) : 2001.
  • 2Hjalmarson A, Goldstein S, Fagerberg B, et al. Effects of controlled release metoprolol on total mortality,hospitalizations, and well-being in patients with heart failure. The Metoprolol CR/XL randomized intervention trial in congestive heart failure(MERIT-HF) [J]. JAMA, 2000,283 :1295.
  • 3Eric J, Eichhorn MD, Michael R, et al. Practical guidlines for initiation of beta-adrenergic blockade in patients with chronic heart failure[J]. Am J Cardiol, 1997, 70 : 794.
  • 4Esler M, Kaye D, Lambert G, et al. Adrenergic nervous system in heart failure[J]. Am J Cardiol, 1997,80 : 7.
  • 5Bristow MR. Mechanism of action of beta-blocking agents in heart failure[J]. Am J Cardiol, 1997,80 : 26.
  • 6Colucci W. Molecular and cellular mechanisms of myocardial failure[J]. Am J Cardiol, 1997,80 : 15.
  • 7Cardiac insufficiency bioprolol study(CIBIS) investigation and committees. A randomized trial of beta-block-ade in heart failure,Circulation,1994,90:1733-1765.
  • 8Michal R,Brietow MR.Mechanism of action of Beta-blocking agents in heart failure.Am J Cardiol,1997,80(HA):26L-40L.
  • 9Esler M. Clinical application of noradrenaline spillover methodology,delineaton if reagional human sympathetic nervous responses.Pharmacol Tosicol,1997,73:243-253.
  • 10Joseph G,Murphy.[美]主编,王海昌主译.MAYO CLINIC心脏病学[M].第2版.西安:第四军医大学出版社,2002:902

共引文献2498

同被引文献78

引证文献13

二级引证文献110

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部